Profile picture

Doctor Pernille Tilma Tonnesen

Aarhus University Hospital, Aarhus (Denmark)
Follow
Logo ESC

Contributor content

Semaglutide eligibility in chronic coronary syndrome: are patients without prior myocardial infarction at comparable risk to the SELECT trial population?
Presentation
Semaglutide eligibility in chronic coronary syndrome: are patients without prior myocardial infarction at comparable risk to the SELECT trial population?
See more
Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction
Presentation
Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction
See more
5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment
Presentation
5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources